Skip to main content

Updates in Mantle Cell Lymphoma

Tracking # 20-899863

Free

There are no ratings for this course

Learn more
Educator I3 HEALTH
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

Discover insights on predictive and prognostic markers, emerging efficacy and safety data, strategies to optimize tolerability for patients receiving novel therapies for mantle cell lymphoma (MCL), and more in this case-based activity presented by John Leonard, MD, the Richard T. Silver Distinguished Professor of Hematology and Medical Oncology at Weill Cornell Medicine. Start the activity now.

Subject areas

This course counts toward the state boards and subject areas below.

Arkansas State Board of Nursing

Certified Nurse Practitioner

0.9h Pharmacotherapeutics continuing education in the area of certification
1h Practice-Focused Continuing Education

Certified Registered Nurse Anesthetist

1h Practice-Focused Continuing Education
0.9h Pharmacotherapeutics continuing education in the area of certification

Clinical Nurse Specialist

1h Practice-Focused Continuing Education
0.9h Pharmacotherapeutics continuing education in the area of certification

Licensed Practical Nurse

1h Practice-Focused Continuing Education

Licensed Psychiatric Technician Nurse

1h Practice-Focused Continuing Education

Registered Nurse

1h Practice-Focused Continuing Education

Registered Nurse Practitioner

1h Practice-Focused Continuing Education

District of Columbia Board of Nursing

Clinical Nurse Specialist

0.9h Pharmacology Component
1h Relevant to Clinical Nurse Specialty

Nurse Practitioner

1h Relevant to Nurse Practitioner Specialty
0.9h Pharmacology Component

Registered Nurse

1h Registered Nurse District of Columbia - Continuing Education

Registered Nurse Anesthetist

1h Relevant to Registered Nurse Anesthetist Specialty
0.9h Pharmacology Component

Florida Board of Nursing - Certified Nursing Assistants

Certified Nursing Assistant

1h General

Georgia Board of Nursing

Licensed Practical Nurse

1h General

Registered Professional Nurse

1h General

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1h Category I CME

Physician and Surgeon Compact License

1h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1h AMA Category I

Physician Assistant

1h AMA Category I

New Mexico Board of Nursing

Certified Nurse Practitioner

0.9h Continuing education related to pharmacology
1h Continuing education relevant to nursing practice
1h Continuing education relevant to CNP nursing specialty

Certified Registered Nurse Anesthetist

0.9h Continuing education related to pharmacology
1h Continuing education relevant to CRNA nursing specialty
1h Continuing education relevant to nursing practice

Clinical Nurse Specialist

0.9h Continuing education related to pharmacology
1h Continuing education relevant to CNS nursing specialty
1h Continuing education relevant to nursing practice

Licensed Practical Nurse

1h Continuing education relevant to the licensed practical nurse

Registered Nurse

1h Continuing education relevant to nursing practice

North Dakota Board of Nursing

Advanced Practice Registered Nurse

0.9h Pharmacotherapy Related to Scope of Practice
1h CE Related to Nursing Practice

Licensed Practical Nurse

1h CE Related to Nursing Practice

Registered Nurse

1h CE Related to Nursing Practice
0.9h Pharmacotherapy Related to Scope of Practice

South Carolina Board of Nursing

Advanced Practice Registered Nurse

1h General
0.9h Pharmacotherapeutics

Licensed Practical Nurse

1h General
0.9h Pharmacotherapeutics

Registered Nurse

0.9h Pharmacotherapeutics
1h General

Tennessee Board of Medical Examiners

Medical Doctor

1h AMA Category I CME

Disclosure statements

i3 Health endorses the standards of the ACCME and ANCC that require everyone in a position to control the content of a CME/NCPD activity to disclose all financial relationships with ineligible companies that are related to the content of the CME/NCPD/CPE activity. CME/NCPD/CPE activities must be balanced, independent of commercial bias, and promote improvements or quality in health care. All recommendations involving clinical medicine must be based on evidence accepted within the medical profession.


A conflict of interest is created when an individual has an opportunity to affect CME/NCPD/CPE content about products or services of a commercial interest with which he/she has a financial relationship, which therefore may bias their opinions and teaching. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, stocks, or other financial benefits.


i3 Health will identify, review, and mitigate all conflicts of interest that speakers, authors, or planners disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation. i3 Health does not endorse any products or services.


Relevant financial relationships exist between the following individuals and commercial interests:

The i3 Health planners, reviewers, and managers have nothing to disclose.


John P. Leonard, MD, discloses that he has served as a consultant for AbbVie, AstraZeneca, Bayer, Bristol Myers Squibb/Celgene, Epizyme, Genentech/Roche, Genmab, Gilead/Kite, Incyte, Janssen, Karyopharm, Miltenyi Biotec, Mustang Bio, Regeneron, Second Genome, and Sutro, and that he has received grants/research support from Epizyme, Genentech, and Janssen.


i3 Health has mitigated all relevant financial relationships.